Answer
For Viramune (nevirapine hemihydrate) 50 mg/5 mL oral suspension, the pharmaceutical incompatibilities section states “Not applicable.”
Sources for this answer
- Viramune 50mg/5ml oral SuspensionBoehringer Ingelheim Limited · emc · SmPC §6.2 Incompatibilities · Version 42Document updated
Sources checked